scholarly journals A registry study of relapsed or refractory multiple myeloma pre‐exposed to three or more prior therapies including a proteasome inhibitor, an immunomodulatory agent and CD38‐targeted monoclonal antibody therapy in England

eJHaem ◽  
2021 ◽  
Author(s):  
Ahmed Elsada ◽  
Amy Zalin‐Miller ◽  
Craig Knott ◽  
Leonidas Caravotas
Keyword(s):  
Multiple Myeloma ◽  
Monoclonal Antibody ◽  
Proteasome Inhibitor ◽  
Antibody Therapy ◽  
Monoclonal Antibody Therapy ◽  
Registry Study ◽  
Refractory Multiple Myeloma ◽  
Immunomodulatory Agent

scholarly journals Outcomes of patients with multiple myeloma refractory to CD38-targeted monoclonal antibody therapy

Leukemia ◽  
2019 ◽  
Vol 33 (9) ◽  
pp. 2266-2275 ◽  
Author(s):  
Ujjawal H. Gandhi ◽  
Robert F. Cornell ◽  
Arjun Lakshman ◽  
Zhubin J. Gahvari ◽  
Elizabeth McGehee ◽  
...  
Keyword(s):  
Multiple Myeloma ◽  
Monoclonal Antibody ◽  
Antibody Therapy ◽  
Monoclonal Antibody Therapy

Anti-CD20 monoclonal antibody therapy in multiple myeloma

2008 ◽  
Vol 141 (2) ◽  
pp. 135-148 ◽  
Author(s):  
Prashant Kapoor ◽  
Patricia T. Greipp ◽  
William G. Morice ◽  
S. Vincent Rajkumar ◽  
Thomas E. Witzig ◽  
...  
Keyword(s):  
Multiple Myeloma ◽  
Monoclonal Antibody ◽  
Antibody Therapy ◽  
Monoclonal Antibody Therapy ◽  
Anti Cd20

Monoclonal antibody therapy in multiple myeloma

Leukemia ◽  
2017 ◽  
Vol 31 (5) ◽  
pp. 1039-1047 ◽  
Author(s):  
C Touzeau ◽  
P Moreau ◽  
C Dumontet
Keyword(s):  
Multiple Myeloma ◽  
Monoclonal Antibody ◽  
Antibody Therapy ◽  
Monoclonal Antibody Therapy

Daratumumab: monoclonal antibody therapy to treat multiple myeloma

2016 ◽  
Vol 52 (10) ◽  
pp. 551 ◽  
Author(s):  
C. Xia ◽  
M. Ribeiro ◽  
S. Scott ◽  
S. Lonial
Keyword(s):  
Multiple Myeloma ◽  
Monoclonal Antibody ◽  
Antibody Therapy ◽  
Monoclonal Antibody Therapy
Sign in / Sign up

Export Citation Format

Share Document